Home > Insider Trading > Filing (0001181431-12-007506)

Filing Details

Accession Number:: 0001181431-12-007506
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-09 18:55:56
Reporting Period:: 2012-02-07

Filing Date:: 2012-02-09
Accepted Time:: 2012-02-09 18:55:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310880	David Hung	C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-02-07	4,800	$70.30	1,209,474	No	4	S	Direct
Common Stock	Disposition	2012-02-07	14,500	$71.21	1,194,974	No	4	S	Direct
Common Stock	Disposition	2012-02-07	23,971	$72.22	1,171,003	No	4	S	Direct
Common Stock	Disposition	2012-02-07	100	$73.01	1,170,903	No	4	S	Direct
Common Stock	Disposition	2012-02-07	100	$73.23	1,170,803	No	4	S	Direct
Common Stock	Disposition	2012-02-08	22,000	$68.40	1,148,803	No	4	S	Direct
Common Stock	Disposition	2012-02-08	28,400	$69.22	1,120,403	No	4	S	Direct
Common Stock	Disposition	2012-02-08	4,700	$70.38	1,115,703	No	4	S	Direct
Common Stock	Disposition	2012-02-08	1,429	$71.56	1,114,274	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	86,060	Indirect	By Trust

Footnotes

Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices between $69.77 and $70.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $70.775 and $71.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $71.78 and $72.53. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $67.80 and $68.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $68.81 and $69.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $69.81 and $70.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $71.22 and $71.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.